Acura Pharma (ACUR) Misses Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts ACUR Hot Sheet
Price: $0.00 --0%
Financial Fact:
Net income (loss): -2.25M
Today's EPS Names:
PMCB, CULP, HURC, More
Financial Fact:
Net income (loss): -2.25M
Today's EPS Names:
PMCB, CULP, HURC, More
Join SI Premium – FREE
Acura Pharma (NASDAQ: ACUR) reported Q1 EPS of ($0.28), $0.02 worse than the analyst estimate of ($0.26).
As of April 30, 2016, our cash, cash equivalents and marketable securities less our compensating balance requirement of $2.5 million was $7.7 million, and we had $7.4 million in term debt financing.
For earnings history and earnings-related data on Acura Pharma (ACUR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ambarella (AMBA) Tops Q2 EPS by 1c; offers guidance
- lululemon athletica (LULU) Tops Q2 EPS by $1.10, Cuts Guidance
- UiPath Inc. (PATH) Reports In-Line Q2 EPS; offers guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
